West Pharmaceutical Services Beats Q2 Targets, Raises 2026 EPS Forecast
West Pharmaceutical Services posts 16% Q2 sales surge, raises 2026 EPS to $3.70‑$3.90, and cuts a $0.22 dividend—boosting investor confidence and stock demand.
- WEST PHARMACEUTICAL SERVICES
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- AI generated
2 minutes to read